跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,198 条关于
“hypomethylating agent”
全部
7,198
临床试验
4,143
药物
655
机构
19
资讯
2,381
去年
Ipilimumab and Nivolumab Show Promise in Higher-Risk Myelodysplastic Syndromes
5个月前
PureTech's LYT-200 Shows Promising Results in Phase 1b Trial for Relapsed/Refractory Blood Cancers
2年前
Taiho Oncology Announces Publication of Final Results from ASCERTAIN Clinical Trial
去年
IO-202 Plus Azacitidine Shows Promise in Treating CMML
2个月前
Epigenetic Therapy NTX-301 Activates Hippo Pathway to Overcome Treatment-Resistant AML
去年
FDA Lifts Clinical Hold on Seclidemstat Trial: 43% Response Rate Observed in Advanced Blood Cancer Study
9个月前
Gallop Oncology's LYT-200 Shows Promising 13.2-Month Survival in Relapsed/Refractory AML Phase 1b Trial
9个月前
Five-Day Azacitidine Regimen Shows Superior Survival Outcomes in Lower-Risk MDS Patients
2年前
Taiho Oncology Presents Real-World Study Data on Oral Decitabine and Cedazuridine for MDS
去年
Poor Outcomes Persist in Secondary AML Patients Previously Treated with Hypomethylating Agents
第 1 页,共 239 页
上一页
下一页